right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
Company profile
Ticker
BRKR
Exchange
Website
CEO
Frank Laukien
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC
SEC CIK
Corporate docs
Subsidiaries
Acquifer Imaging GmbH • Acuity Spatial Genomics, Inc. • Agapetus GmbH • Alicona Imaging GmbH • Anasys Instruments Corporation • Biognosys, AG • Biognosys, Inc. • Bruker (Beijing) Scientific Technology Co., Ltd. • Bruker (Malaysia) SDN. BHD. • Bruker Arabia Limited ...
IRS number
43110160
BRKR stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
2 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
13 Feb 24
8-K
Entry into a Material Definitive Agreement
12 Feb 24
8-K
Entry into a Material Definitive Agreement
2 Feb 24
8-K
Entry into a Material Definitive Agreement
18 Jan 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Entry into a Material Definitive Agreement
26 Dec 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Bruker Reports Third Quarter 2023 Financial Results
2 Nov 23
Transcripts
BRKR
Earnings call transcript
2023 Q4
13 Feb 24
BRKR
Earnings call transcript
2023 Q3
2 Nov 23
BRKR
Earnings call transcript
2023 Q2
3 Aug 23
BRKR
Earnings call transcript
2023 Q1
4 May 23
BRKR
Earnings call transcript
2023 Q1
4 May 23
BRKR
Earnings call transcript
2022 Q4
9 Feb 23
BRKR
Earnings call transcript
2022 Q3
3 Nov 22
BRKR
Earnings call transcript
2022 Q2
4 Aug 22
BRKR
Earnings call transcript
2022 Q1
4 May 22
BRKR
Earnings call transcript
2021 Q4
11 Feb 22
Latest ownership filings
4
FRANK H LAUKIEN
12 Mar 24
4
Hermann Fritz Requardt
6 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
Falko Busse
1 Mar 24
144
Notice of proposed sale of securities
28 Feb 24
4
Burkhard Prause
26 Feb 24
144
Notice of proposed sale of securities
22 Feb 24
SC 13G/A
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
9 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 366.90 mm | 366.90 mm | 366.90 mm | 366.90 mm | 366.90 mm | 366.90 mm |
Cash burn (monthly) | 70.43 mm | 21.87 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 469.85 mm | 145.87 mm | n/a | n/a | n/a | n/a |
Cash remaining | -102.95 mm | 221.03 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | -1.5 | 10.1 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
79.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 338 |
Opened positions | 44 |
Closed positions | 52 |
Increased positions | 120 |
Reduced positions | 136 |
13F shares | Current |
---|---|
Total value | 6.70 tn |
Total shares | 108.82 mm |
Total puts | 42.90 k |
Total calls | 122.80 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
T. Rowe Price Investment Management | 13.16 mm | $823.25 bn |
Vanguard | 10.33 mm | $643.63 bn |
BLK Blackrock | 10.19 mm | $634.55 bn |
FMR | 10.01 mm | $623.58 bn |
Pallas Capital Advisors | 9.48 mm | $520.57 bn |
Massachusetts Financial Services | 7.84 mm | $488.48 bn |
RTW Investments | 3.38 mm | $210.68 bn |
STT State Street | 3.10 mm | $193.03 bn |
Alliancebernstein | 2.35 mm | $146.69 bn |
Fuller & Thaler Asset Management | 2.23 mm | $139.15 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | Falko Busse | Common Stock | Sell | Dispose S | No | No | 84.48 | 1,500 | 126.72 k | 32,859 |
28 Feb 24 | Falko Busse | Common Stock | Sell | Dispose S | No | No | 84.97 | 12,770 | 1.09 mm | 34,359 |
28 Feb 24 | Falko Busse | Common Stock | Sell | Dispose S | No | No | 86.06 | 13,852 | 1.19 mm | 47,129 |
28 Feb 24 | Falko Busse | Common Stock | Option exercise | Acquire M | No | No | 41.95 | 4,641 | 194.69 k | 60,981 |
28 Feb 24 | Falko Busse | Common Stock | Option exercise | Acquire M | No | No | 34.02 | 4,384 | 149.14 k | 56,340 |
28 Feb 24 | Falko Busse | Common Stock | Option exercise | Acquire M | No | No | 22.19 | 7,097 | 157.48 k | 51,956 |
28 Feb 24 | Falko Busse | Common Stock | Option exercise | Acquire M | No | No | 19.82 | 12,000 | 237.84 k | 44,859 |
28 Feb 24 | Falko Busse | Stock Option (Right to Purchase) Common Stock | Option exercise | Dispose M | No | No | 41.95 | 4,641 | 194.69 k | 0 |
28 Feb 24 | Falko Busse | Stock Option (Right to Purchase) Common Stock | Option exercise | Dispose M | No | No | 34.02 | 4,384 | 149.14 k | 0 |
28 Feb 24 | Falko Busse | Stock Option (Right to Purchase) Common Stock | Option exercise | Dispose M | No | No | 22.19 | 7,097 | 157.48 k | 0 |
News
NanoString Technologies To Be Acquired By Bruker For ~$392.6M In Cash Consideration, Plus Assumption Of Certain Liabilities; Bruker Wins Competitive Auction
17 Apr 24
Goldman Sachs Maintains Sell on Bruker, Raises Price Target to $74
10 Apr 24
Bruker Introduces NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
8 Apr 24
Biognosys, Alamar Biosciences Forge Strategic Partnership In Proteomics
4 Apr 24
UBS Maintains Buy on Bruker, Raises Price Target to $102
1 Mar 24
Press releases
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
8 Apr 24
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
8 Apr 24
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
4 Apr 24
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
4 Apr 24
Bruker Selected as 'Company of the Year' by Instrument Business Outlook
1 Apr 24